International Invited Speakers
Professor Laurie A. Loevner, MD
Professor of Radiology, Neurosurgery, Otorhinolaryngology:Head & Neck Surgery, and Ophthalmology
University of Pennsylvania Health System
Laurie A. Loevner, MD, is Chief of the Neuroradiology Division at the University of Pennsylvania Health System and in the Perelman School of Medicine at the University of Pennsylvania. Dr. Loevner received her MD from the University of Pennsylvania, and completed a residency in Diagnostic Radiology at the University of Michigan. Following a two year fellowship in neuroradiology back at the University of Pennsylvania “PENN”, Dr. Loevner joined the faculty as an Assistant Professor. She rapidly ascended through the ranks to Professor of Radiology within ten years, and holds joint appointments in the departments of Otorhinolaryngology: Head and Neck Surgery, Neurosurgery, and Ophthalmopathy at the University of Pennsylvania.
Dr. Loevner reflects the tri-partite mission of clinical, educational and academic excellence. She was the recipient of the IS Ravdin Master Clinician Award in 2009 in recognition of her clinical expertise and compassionate delivery of care to patients. She is a founding member of the Academy of Master Clinicians, and has been named a “Top Doc” in Neuroradiology in Philadelphia Magazine almost every year since 2000. Dr. Loevner is a respected local, national and international educator and lecturer, and is the recipient of numerous teaching awards from medical students, residents and fellows. She is widely respected in the global Neuroradiology community for her expertise and leadership in the field, and has served as President of the American Society of Neuroradiology in 2015-2016, President of the American Society of Head and Neck Radiology in 2009-2010, and President of the Eastern Neuroradiological Society in 2000-2001. Through her grant funded research Dr. Loevner has made important contributions to our understanding of the radiologic manifestations of head and neck cancer, as well as the role of imaging in determining surgical candidacy. She has also been a leader in the clinical translation of functional imaging biomarkers to predict and monitor the treatment response of head and neck cancer. She was the 2012 Recipient of the Prize of Innovation and Excellence from the Canadian Radiological Society for her body of research in head and neck MRI. Dr. Loevner is the 2019 recipient of the American Society of Head and Neck Radiology “Gold Medal”. Dr. Loevner has a focused interest in the academic mentoring of trainees and junior faculty, and in multidisciplinary collaboration. She continues to use her substantial energies to raise the next generation of neuroradiologists.
Associate Professor Bruno Giuffrè, MBBS, FRANZCR
Radiology Department, Royal North Shore Hospital
Associate Professor Bruno Giuffrè was a Senior Staff Specialist Radiologist in Radiology Department at Royal North Shore Hospital and North Shore Private Hospital for nearly 30 years, until last year when he retired from much of his clinical work. He is now an Honorary Medical Officer but continues in many of his teaching roles as well as continuing as a Visiting Medical Officer in several breast imaging clinics – BreastScreen NSW, Breast Screen Tasmania and Sydney Breast Clinic.
Over the years on the Royal North Shore campus he was the main breast imaging specialist. He was instrumental in developing and supervising breast imaging and the multidisciplinary approach to breast problems on the Northern Sydney campus. He was the chairman of the committee establishing BreastScreen Northern Sydney Central Coast as well as helping develop the multidisciplinary team meetings at RNS and North Shore Private Hospital.
As well he has been the lead in MSK imaging on campus. He founded and continued as chairman of the MSK meetings on campus: Knee, Shoulder, Elbow and Rheumatology - for nearly 20 years. He was a founding member of the sub-speciality MSK group of RANZCR: Australasian Musculoskeletal Imaging Group and has convened several AMSIG meetings including the AMSIG 2020 meeting in Sydney.
He has always been interested and involved in Medical Informatics and the presentation of medical imaging to clinicians and students, at all levels.
Teaching – of medical students, junior medical officers, radiologists in training and radiologist colleagues and other clinical colleagues as well as radiographers, nurses and community colleagues – has always been and continues as a strong interest.
Professor Corinne Doll
Tom Baker Cancer Center
President of Canadian Association of Radiation Oncology
Dr. Corinne Doll is a Clinical Professor in the Department of Oncology at the University of Calgary and Radiation Oncologist at Tom Baker Cancer Centre. She completed medical school and radiation oncology residency training at the University of British Columbia in Vancouver, and Fellowship training at Princess Margaret Hospital in Toronto. She was recruited to Calgary in 2001, and has developed clinical and research interests in gynecologic and gastrointestinal cancers. She is Leader of Translational Research and Clinical Brachytherapy Lead, Division of Radiation Oncology, and Deputy Medical Director of the Tom Baker Cancer Centre. She is Co-Chair of the Cervical Cancer Working Group of the Canadian Clinical Trials Group (CCTG), Executive Committee member of the CCTG Gyne Disease Site Group, Special Expert of the NCI Gynecologic Cancer Steering Committee, and President of the Canadian Association of Radiation Oncology.
Professor Vedang Murthy
Advanced Center for Treatment Research and Education in Cancer / Tata Memorial Center
Vedang Murthy, MD, DNB, DipEPP, is a Professor of Radiation Oncology at Tata Memorial Hospital, Mumbai. Dr Murthy's area of expertise is in Urological Cancer. Dr. Murthy did his training in the field of Radiation Oncology from Tata Memorial Hospital in 2002 before going to the United Kingdom where he worked at The Royal Marsden NHS Foundation Hospital, London for a period of 4 years in the Academic Radiotherapy Unit. He also undertook a Diploma in Epidemiology and Biostatistics from the London School of Health and Tropical Medicine. He has over 120 publications in peer reviewed international journals.
Dr Murthy is currently running several investigator initiated clinical trials including randomised controlled trials in prostate and bladder cancer and is a part of international co-operative groups in GU Oncology. The main areas of interest within GU oncology are high risk prostate cancer, SBRT for prostate and kidney cancer, oligometastatic prostate cancer, bladder preservation and adjuvant radiotherapy in bladder cancer.